.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Citi
Boehringer Ingelheim
Fish and Richardson
Chinese Patent Office
Express Scripts
Farmers Insurance
Deloitte
Harvard Business School
Chubb

Generated: November 23, 2017

DrugPatentWatch Database Preview

CREON Drug Profile

« Back to Dashboard

What is the patent landscape for Creon, and when can generic versions of Creon launch?

Creon is a drug marketed by Abbvie and is included in one NDA. There is one patent protecting this drug.

This drug has forty-six patent family members in twenty-two countries.

The generic ingredient in CREON is pancrelipase (amylase;lipase;protease). There are six drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the pancrelipase (amylase;lipase;protease) profile page.

Summary for CREON

US Patents:1
Applicants:1
NDAs:1
Suppliers / Packagers: 3
Clinical Trials: 14
Drug Prices:see details
DailyMed Link:CREON at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-002Apr 30, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-003Apr 30, 2009RXYesYes► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-001Apr 30, 2009RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-004Jul 12, 2011RXYesNo► Subscribe► SubscribeY ► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-004Jul 12, 2011RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► Subscribe► Subscribe
Abbvie
CREON
pancrelipase (amylase;lipase;protease)
CAPSULE, DELAYED RELEASE;ORAL020725-005Mar 14, 2013RXYesNo► Subscribe► SubscribeY ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Tradename: CREON

Country Document Number Estimated Expiration
Canada2619477► Subscribe
Norway20081379► Subscribe
Japan5284092► Subscribe
New Zealand565959► Subscribe
Hong Kong1121037► Subscribe
Hong Kong1119559► Subscribe
Spain2341284► Subscribe
Germany602006004471► Subscribe
Germany602006012346► Subscribe
CroatiaP20100269► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Baxter
Accenture
Dow
Harvard Business School
UBS
Cantor Fitzgerald
Fish and Richardson
Cerilliant
Cipla
US Army

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot